What could your Novo Nordisk investment become?

Is Novo Nordisk a dividend stock?

Yes — Novo Nordisk (NVO) pays a dividend yield of 1.6%, paid twice a year. It pays out about 30% of its earnings as dividends, leaving room to reinvest in growth and potentially raise the dividend over time.

Novo Nordisk pays dividends twice a year, so investors receive income twice a year.

What sector is Novo Nordisk in?

Novo Nordisk (NVO) is part of the Healthcare sector. Healthcare covers pharmaceuticals, medical devices, and health services. Demand tends to hold up across economic cycles because people need care in good times and bad. Novo Nordisk trades at a price-to-earnings (P/E) ratio of around 28, which reflects how much investors are currently willing to pay for each dollar of the company's earnings.

💡 Danish pharma. Diabetes and weight-loss drugs (Ozempic, Wegovy).

⚡ Makes Ozempic — a phenomenon of today's market.

How is this projection calculated?

The calculator above assumes a 6% average annual return — roughly in line with long-term stock-market averages — and compounds your investment year by year. Dividend income is estimated from Novo Nordisk's current 1.6% yield. These are educational projections based on historical averages. Actual returns may vary, and your capital is at risk.